Opportunity Information: Apply for RFA CK 10 004
Apply for RFA CK 10 004
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Assessment of Post treatment Lyme disease Syndrome (PLDS) (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.942 Research, Prevention, and Education Programs on Lyme Disease in the United States.
- This funding opportunity was created on Mar 3, 2010 and posted on Mar 3, 2010.
- Applicants must submit their applications by Apr 14, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $300,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $300,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligible Institutions You may submit an application(s) if your organization has any of the following characteristics Public nonprofit organizations Private nonprofit organizations Small, minority, and women owned businesses Universities Colleges Research institutions Hospitals Community based organizations Faith based organizations Federally recognized or state recognized American Indian/Alaska Native tribal governments American Indian/Alaska Native tribally designated organizations Alaska Native health corporations Urban Indian health organizations Tribal epidemiology centers State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) Political subdivisions of States (in consultation with States) A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If you are applying as a bona fide agent of a state or local government, you must provide a letter from the state or local government as documentation of your status. Attach this documentation behind the first page of your application form or for electronic applications, use a PDF file and attach as Other Documents and label as appropriate.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The CDC grant opportunity titled "Assessment of Post treatment Lyme disease Syndrome (PLDS) (R01)" (Funding Opportunity Number RFA CK 10 004) was a discretionary research grant announced for Fiscal Year 2010 to support work focused on post treatment Lyme disease syndrome. The core goal of the program was to generate clearer, evidence-based insight into the epidemiological and clinical characteristics of PLDS, with the intent that the findings could help shape future treatment approaches and inform prevention strategies. In practical terms, the CDC was seeking research that could better define who develops PLDS, what symptoms and clinical patterns are most common, how the syndrome presents over time, and what measurable features might distinguish PLDS from other conditions with overlapping symptoms. The award was categorized under CFDA 93.942, which covers Research, Prevention, and Education Programs on Lyme Disease in the United States, signaling that the work was meant to contribute directly to the national public health and research response to Lyme disease.
From a funding and award structure standpoint, the opportunity anticipated making a single award, with an estimated total funding amount of $300,000 and an award ceiling of $300,000 (no stated minimum award floor). There was no cost sharing or matching requirement, which meant applicants were not required to contribute non-federal funds as a condition of receiving the grant. The funding instrument type was a grant and the activity category was health, aligning it with biomedical and public health research efforts rather than service delivery or infrastructure development.
Eligibility was broad and designed to include a wide range of organizations capable of conducting rigorous research. Eligible applicants included public and private nonprofit organizations, universities and colleges, research institutions, hospitals, community-based and faith-based organizations, and small, minority-owned, and women-owned businesses. The announcement also included multiple government and tribal entities, such as federally or state recognized American Indian/Alaska Native tribal governments, tribally designated organizations, Alaska Native health corporations, Urban Indian health organizations, tribal epidemiology centers, and state and local governments (including U.S. territories and freely associated states listed in the notice). The opportunity also allowed applications from bona fide agents of states or local governments, but required documentation in the form of a letter from the relevant government confirming that status, attached to the application materials.
The timeline for the opportunity indicates it was posted and created on March 3, 2010, with an original and current closing date of April 14, 2010, and an archive date of May 14, 2010. That short application window suggests the CDC was moving on a fairly tight schedule to fund a targeted project intended to address specific evidence gaps around PLDS. For applicants at the time, this would have implied the need for a well-developed research plan, clear methodology, and strong capacity to execute within the scope and budget of a single-project R01-style award.
For administrative or access issues related to the full announcement, the CDC directed applicants to the Procurement and Grants Office (TIMS) and provided contact details (phone 770-488-2700 and email PGOTIM@cdc.gov). Overall, the opportunity was a narrowly focused research investment meant to advance understanding of PLDS in ways that could ultimately support better clinical guidance and public health decision-making around post-treatment outcomes in Lyme disease.
Frequently Asked Questions (FAQs)
What is the title of this CDC grant opportunity?
The opportunity is titled "Assessment of Post treatment Lyme disease Syndrome (PLDS) (R01)."
What is the Funding Opportunity Number?
The Funding Opportunity Number is RFA CK 10 004.
Which federal agency offered this grant?
This discretionary research grant opportunity was offered by the Centers for Disease Control and Prevention (CDC).
What was the main purpose of the program?
The core goal was to generate clearer, evidence-based insight into the epidemiological and clinical characteristics of post treatment Lyme disease syndrome (PLDS), so findings could help shape future treatment approaches and inform prevention strategies.
What kinds of research topics was the CDC looking to support?
The CDC sought research aimed at better defining who develops PLDS, identifying common symptoms and clinical patterns, describing how PLDS presents over time, and finding measurable features that might distinguish PLDS from other conditions with overlapping symptoms.
What is the CFDA number associated with this grant?
The award was categorized under CFDA 93.942.
What does CFDA 93.942 cover?
CFDA 93.942 covers Research, Prevention, and Education Programs on Lyme Disease in the United States, indicating the funded work was intended to contribute to the national public health and research response to Lyme disease.
What type of funding instrument was used?
The funding instrument type was a grant.
What was the activity category for this opportunity?
The activity category was health.
How many awards did the CDC anticipate making?
The opportunity anticipated making a single award.
What was the estimated total funding amount?
The estimated total funding amount was $300,000.
What was the award ceiling?
The award ceiling was $300,000.
Was there a minimum award amount (award floor)?
No minimum award floor was stated.
Was cost sharing or matching required?
No. There was no cost sharing or matching requirement, meaning applicants were not required to contribute non-federal funds as a condition of receiving the grant.
Who was eligible to apply?
Eligibility was broad and included public and private nonprofit organizations, universities and colleges, research institutions, hospitals, community-based organizations, faith-based organizations, and small, minority-owned, and women-owned businesses.
Were government entities eligible to apply?
Yes. Eligible applicants included state and local governments (including U.S. territories and freely associated states listed in the notice), as well as federally or state recognized American Indian/Alaska Native tribal governments and other tribal entities described in the announcement.
Which tribal and tribal-related entities were specifically mentioned as eligible?
The announcement included federally or state recognized American Indian/Alaska Native tribal governments, tribally designated organizations, Alaska Native health corporations, Urban Indian health organizations, tribal epidemiology centers, and other listed tribal entities.
Could bona fide agents of states or local governments apply?
Yes. Applications were allowed from bona fide agents of states or local governments, but documentation was required.
What documentation was required for bona fide agents of states or local governments?
A letter from the relevant government confirming the applicant's status as a bona fide agent was required, and it needed to be attached to the application materials.
When was the opportunity created and posted?
It was created and posted on March 3, 2010.
What was the application closing date?
The original and current closing date was April 14, 2010.
When was the opportunity archived?
The archive date was May 14, 2010.
What did the short application window suggest about expectations for applicants?
The short window suggested applicants needed a well-developed research plan, clear methodology, and strong capacity to execute within the scope and budget of a single-project, R01-style award.
Who should applicants contact for administrative or access issues related to the full announcement?
For administrative or access issues, the CDC directed applicants to the Procurement and Grants Office (TIMS).
What contact information was provided for the Procurement and Grants Office (TIMS)?
Phone: 770-488-2700. Email: PGOTIM@cdc.gov.
How was this opportunity described in terms of overall focus?
It was described as a narrowly focused research investment intended to advance understanding of PLDS in ways that could support better clinical guidance and public health decision-making around post-treatment outcomes in Lyme disease.
Browse more opportunities from the same category: Health
Next opportunity: Long Term Outcomes of Infants Identified with Congenital CMV Infection (U01)
Previous opportunity: Improved Diagnostics for Lyme Borreliosis (U01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA CK 10 004
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA CK 10 004) also looked into and applied for these:
| Funding Opportunity |
|---|
| Long Term Outcomes of Infants Identified with Congenital CMV Infection (U01) Apply for RFA IP 10 006 Funding Number: RFA IP 10 006 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $550,000 |
| MAPGen Knowledge Base (MAPGenKB) and Coordination Center (U01) Apply for RFA HL 11 004 Funding Number: RFA HL 11 004 Agency: National Institutes of Health Category: Health Funding Amount: $650,000 |
| Cooperative Agreement with the Kenya Ministry of Public Health and Sanitation (KMOPHS) Apply for CDC RFA GH10 1004 Funding Number: CDC RFA GH10 1004 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Supporting the Republican Blood Center (RBC) in the Implementation of Blood Safety Activities in the Republic of Uzbekistan under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10170 Funding Number: CDC RFA PS10 10170 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Providing HIV Prevention, Treatment, and Care Services to Incarcerated Population in the Kyrgyz Republic under the President s Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10171 Funding Number: CDC RFA PS10 10171 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| PPHF 2012 Public Health Workforce Association of Public Health Laboratories (APHL) financed solely by 2012 Prevention and Public Health Funds Apply for CDC RFA HM10 1001 Funding Number: CDC RFA HM10 1001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,983,074 |
| Providing HIV Prevention, Treatment, and Care Services to the Incarcerated Population in the Republic of Kazakhstan under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10172 Funding Number: CDC RFA PS10 10172 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Providing HIV Prevention, Treatment, and Care Services to the Incarcerated Population in the Republic of Tajikistan under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10173 Funding Number: CDC RFA PS10 10173 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Developing a Regional Public Health Surveillance and Laboratory Network for Central America with the Secretara General del Sistema de la Integracin Centroamericana (SG SICA) / Consejo de Ministros de Salud de Centroamrica (COMISCA) Apply for CDC RFA GH10 1005 Funding Number: CDC RFA GH10 1005 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Hepatitis C Treatment Expansion Initiative Demonstration Sites Apply for HRSA 10 090 Funding Number: HRSA 10 090 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Poison Center Support and Enhancement Grant Program, Incentive Grants Apply for HRSA 10 051 Funding Number: HRSA 10 051 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Improving HIV Prevention Initiatives in Communities in the Republic of Zambia under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10109 Funding Number: CDC RFA PS10 10109 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,500,000 |
| ARRA CHARN Central Data Management Coordination Center Apply for HRSA 10 206 Funding Number: HRSA 10 206 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| EMSC Targeted Issue Grants Apply for HRSA 10 062 Funding Number: HRSA 10 062 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| Global Partnerships with Non Governmental Organizations (NGO s) Apply for CDC FOA GH10 1003 Funding Number: CDC FOA GH10 1003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| AETC National Multicultural Center Apply for HRSA 10 149 Funding Number: HRSA 10 149 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| NIAID Advanced Technology SBIR (NIAID AT SBIR R43/R44) Apply for PA 10 123 Funding Number: PA 10 123 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| NIAID Advanced Technology STTR (NIAID AT STTR R41/R42) Apply for PA 10 124 Funding Number: PA 10 124 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NHLBI Research Centers at Minority Serving Institutions (P30) Apply for RFA HL 11 019 Funding Number: RFA HL 11 019 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Laboratory Technical Implementation Assistance for Public Health Cooperative Agreement Program Apply for CDC RFA HK10 1001ARRA10 Funding Number: CDC RFA HK10 1001ARRA10 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA CK 10 004", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.